These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10501419)

  • 1. High disease activity at baseline does not prevent a remission in patients with systemic lupus erythematosus.
    Formiga F; Moga I; Pac M; Mitjavila F; Rivera A; Pujol R
    Rheumatology (Oxford); 1999 Aug; 38(8):724-7. PubMed ID: 10501419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.
    Ugarte-Gil MF; Wojdyla D; Pons-Estel GJ; Quintana R; Gómez-Puerta JA; Catoggio LJ; Alvarellos A; Saurit V; Borba E; Sato E; Costallat L; Da Silva NA; Iglesias-Gamarra A; Neira O; Reyes-Llerena G; Cardiel MH; Amigo MC; Acevedo-Vásquez E; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA
    J Rheumatol; 2019 Oct; 46(10):1299-1308. PubMed ID: 30824636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining Low Disease Activity in Systemic Lupus Erythematosus.
    Polachek A; Gladman DD; Su J; Urowitz MB
    Arthritis Care Res (Hoboken); 2017 Jul; 69(7):997-1003. PubMed ID: 27696791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+CD25highFOXP3+ T regulatory cells as a biomarker of disease activity in systemic lupus erythematosus: a prospective study.
    Tselios K; Sarantopoulos A; Gkougkourelas I; Boura P
    Clin Exp Rheumatol; 2014; 32(5):630-9. PubMed ID: 25197969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged clinical remission in patients with systemic lupus erythematosus.
    Steiman AJ; Urowitz MB; Ibañez D; Papneja A; Gladman DD
    J Rheumatol; 2014 Sep; 41(9):1808-16. PubMed ID: 25086082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between disease onset patterns of Egyptian juvenile and adult systemic lupus erythematosus (single centre experience).
    Abdel-Nabi HH; Abdel-Noor RA
    Lupus; 2018 May; 27(6):1039-1044. PubMed ID: 29460702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment pathways in an inception lupus cohort over the first three years.
    Hanly JG; Sayani A; Doucette S; Iczkovitz S; Terres JAR
    Lupus; 2017 Feb; 26(2):119-124. PubMed ID: 27365369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged remission in systemic lupus erythematosus.
    Urowitz MB; Feletar M; Bruce IN; Ibañez D; Gladman DD
    J Rheumatol; 2005 Aug; 32(8):1467-72. PubMed ID: 16078321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile systemic lupus erythematosus: onset patterns and short-term outcome in Egyptian children, a single-center experience.
    Abdel-Hafez MA; Abdel-Nabi H
    Lupus; 2015 Nov; 24(13):1455-61. PubMed ID: 26223297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with remission in patients with systemic lupus erythematosus: new insights into a desirable state.
    Romo-Tena J; la Garza RR; Bartnicki-Navarrete I; Alcocer-Varela J; Gómez-Martin D
    Clin Rheumatol; 2018 Nov; 37(11):3033-3042. PubMed ID: 30056524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term follow-up of patients with refractory systemic lupus erythematosus during rituximab treatment].
    Tsanian MÉ; Solov'ev SK; Torgashina AV; Aleksandrova EN; Radenska-Lopovok SG; Nikolaeva EV; Khrennikova IaB; Nasonov EL
    Ter Arkh; 2014; 86(5):40-9. PubMed ID: 25026801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the incidence of discoid lupus erythematosus in patients with systemic lupus erythematosus and its relationship to disease activity.
    Saghafi M; Hashemzadeh K; Sedighi S; Yazdanpanah MJ; Rezaieyazdi Z; Sahebari M; Esmaily H
    J Cutan Med Surg; 2014 Oct; 18(5):316-9. PubMed ID: 25186992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.
    Touma Z; Gladman DD; Ibañez D; Taghavi-Zadeh S; Urowitz MB
    J Rheumatol; 2011 Nov; 38(11):2395-9. PubMed ID: 21885488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of the Levels of C4d-bearing Reticulocytes and High-avidity Anti-dsDNA Antibodies with Disease Activity in Systemic Lupus Erythematosus.
    Mora C; Medina-Rosas J; Santos AM; Jaimes DA; Arbeláez AM; Romero C; Cortes A; Londono J
    J Rheumatol; 2016 Sep; 43(9):1657-64. PubMed ID: 27134246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.
    Fanouriakis A; Adamichou C; Koutsoviti S; Panopoulos S; Staveri C; Klagou A; Tsalapaki C; Pantazi L; Konsta S; Mavragani CP; Dimopoulou D; Ntali S; Katsikas G; Boki KA; Vassilopoulos D; Konstantopoulou P; Liossis SN; Elezoglou A; Tektonidou M; Sidiropoulos P; Erden A; Sfikakis PP; Bertsias G; Boumpas DT
    Semin Arthritis Rheum; 2018 Dec; 48(3):467-474. PubMed ID: 29555348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of systematic lupus erythematosus.
    Drenkard C; Villa AR; Garcia-Padilla C; Pérez-Vázquez ME; Alarcón-Segovia D
    Medicine (Baltimore); 1996 Mar; 75(2):88-98. PubMed ID: 8606630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus.
    Urquizu-Padilla M; Balada E; Cortés F; Pérez EH; Vilardell-Tarrés M; Ordi-Ros J
    J Rheumatol; 2009 May; 36(5):953-60. PubMed ID: 19332622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of T helper cell subsets in pathogenesis of Systemic Lupus Erythematosus and their relation to disease activity.
    Al-Saleh J; el-Eissawy S
    Egypt J Immunol; 2006; 13(2):41-8. PubMed ID: 18689270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N; Ingsathit A; Rattanasiri S; Ngamjanyaporn P; Kasitanont N; Chawanasuntorapoj R; Pichaiwong W; Anutrakulchai S; Sangthawan P; Ophascharoensuk V; Avihingsanon Y; Sumethkul V
    Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission and low disease activity in Polish patients with systemic lupus erythematosus - real-life, five-year follow-up outcomes.
    Pawlak-Buś K; Schmidt W; Leszczyński P
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(3):949-959. PubMed ID: 36808341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.